Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinic Oct 3, 2025 Cartography Names Dirk Nagorsen, M.D., as Chief Medical Officer in Expansion of Its Clinical Team Sep 3, 2025 Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors Oct 29, 2024 Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs May 28, 2024
Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinic Oct 3, 2025
Cartography Names Dirk Nagorsen, M.D., as Chief Medical Officer in Expansion of Its Clinical Team Sep 3, 2025
Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors Oct 29, 2024
Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs May 28, 2024
